Literature DB >> 16195161

Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification.

M-C Park1, S-W Lee, Y-B Park, N S Chung, S-K Lee.   

Abstract

OBJECTIVES: To investigate the clinical characteristics and outcomes of Takayasu's arteritis (TA) using standardized criteria for diagnosis, disease activity, and angiographic classification, and to identify the predictive factors for remission, angiographic progression, and mortality in patients with TA.
METHODS: One hundred and eight patients who fulfilled the 1990 American College of Rheumatology (ACR) classification criteria for TA were studied. Their clinical features, laboratory findings, angiographic findings, and clinical outcomes were evaluated retrospectively. The disease activities were assessed using the National Institutes of Health (NIH) criteria for active disease, and the angiographic types were classified using the International TA Conference in Tokyo 1994 angiographic classification.
RESULTS: Angiographic classification showed that type I was the most common, followed by types V and IV. Ninety-one patients had active disease at diagnosis, and remission was achieved in 81.3% of them. Among those who experienced remission and those who had stable disease at diagnosis, 28.6% experienced a relapse. A low erythrocyte sedimentation rate (ESR) at diagnosis and treatment with glucocorticoid were found to be independent predictors for remission, and the stable disease activity at diagnosis was an independent predictor for the quiescence of vascular lesions on follow-up angiography. Survival rates were 92.9% at the fifth year and 87.2% at the tenth year, and the presence of two or more complications was a risk factor for mortality.
CONCLUSIONS: These findings could provide useful information on the clinical features, angiographic findings, and outcomes in TA, particularly on the assessment of patients at risk of a poor outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195161     DOI: 10.1080/03009740510026526

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  56 in total

1.  Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study.

Authors:  G A Hooisma; H Balink; P M Houtman; R H J A Slart; K D F Lensen
Journal:  Clin Rheumatol       Date:  2012-02-10       Impact factor: 2.980

2.  Takayasu's arteritis: clinical features and outcomes of 125 patients in China.

Authors:  Xiao-Liang Cong; Sheng-Ming Dai; Xiang Feng; Zhi-Wei Wang; Qing-Sheng Lu; Liang-Xi Yuan; Xian-Xian Zhao; Dong-Bao Zhao; Zai-Ping Jing
Journal:  Clin Rheumatol       Date:  2010-06-30       Impact factor: 2.980

Review 3.  Aortitis.

Authors:  Heather L Gornik; Mark A Creager
Journal:  Circulation       Date:  2008-06-10       Impact factor: 29.690

4.  Longitudinal study of 16 patients with Takayasu's arteritis: clinical features and therapeutic management.

Authors:  Ljiljana Petrovic-Rackov; Nada Pejnovic; Miodrag Jevtic; Nemanja Damjanov
Journal:  Clin Rheumatol       Date:  2008-09-17       Impact factor: 2.980

5.  Anti-cytokine treatment for Takayasu arteritis: State of the art.

Authors:  Enrico Tombetti; Maria Chiara Di Chio; Silvia Sartorelli; Enrica Bozzolo; Maria Grazia Sabbadini; Angelo A Manfredi; Elena Baldissera
Journal:  Intractable Rare Dis Res       Date:  2014-02

6.  Outcomes of different treatments on Takayasu's arteritis.

Authors:  Yu Xiao; Jian Zhou; Xiaolong Wei; Yudong Sun; Lei Zhang; Jiaxuan Feng; Rui Feng; Zhiqing Zhao; Zaiping Jing
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

7.  Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Authors:  Haner Direskeneli; Sibel Z Aydin; Tanaz A Kermani; Eric L Matteson; Maarten Boers; Karen Herlyn; Raashid A Luqmani; Tuhina Neogi; Philip Seo; Ravi Suppiah; Gunnar Tomasson; Peter A Merkel
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

Review 8.  Advances in the diagnosis, assessment and outcome of Takayasu's arteritis.

Authors:  Fatma Alibaz-Oner; Sibel Zehra Aydin; Haner Direskeneli
Journal:  Clin Rheumatol       Date:  2012-12-28       Impact factor: 2.980

Review 9.  Takayasu arteritis--advances in diagnosis and management.

Authors:  Justin C Mason
Journal:  Nat Rev Rheumatol       Date:  2010-07       Impact factor: 20.543

10.  Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study.

Authors:  Priscille Couture; Thibaud Chazal; Charlotte Rosso; Julien Haroche; Anne Léger; Baptiste Hervier; Sandrine Deltour; Zahir Amoura; Fleur Cohen Aubart
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.